• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Report > Pharmaceutical > Neurodegenerative Disease

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

New for 2017!
Filter
Title Search
1 - 25 of 259 Products Sort by Display
*
Published by
Frost & Sullivan
Product code
492209
Published
April 12, 2017
Content info
61 Pages
Price
USD 4950
Sample available
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
489881
Published
March 21, 2017
Content info
797 Pages
Price
USD 3995
Sample available
Acute Stress Disorder Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
349793
Published
March 15, 2017
Content info
55 Pages
Price
USD 2500
Sample available
Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
306642
Published
March 15, 2017
Content info
60 Pages
Price
USD 2500
Sample available
Epilepsy - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
232793
Published
March 15, 2017
Content info
382 Pages
Price
USD 2000
Sample available
Complex Regional Pain Syndrome - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
465218
Published
March 8, 2017
Content info
37 Pages
Price
USD 2000
Sample available
Global Neuropathy Pain Treatment Market 2017-2021
Published by
TechNavio (Infiniti Research Ltd.)
Product code
481449
Published
March 7, 2017
Content info
70 Pages
Price
USD 3500
Sample available
Lewy Body Dementia in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
452414
Published
March 1, 2017
Content info
48 pages
Price
USD 6100
Sample available
Alzheimer's Disease in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
452413
Published
March 1, 2017
Content info
56 pages
Price
USD 6100
Sample available
Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
250308
Published
March 1, 2017
Content info
600+ Pages
Price
USD 3495
Sample available
Global Alzheimer's Disease Partnering 2010 to 2017
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
239673
Published
March 1, 2017
Content info
100+ Pages
Price
USD 1495
Sample available
Bell's Palsy Forecast in 15 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
436080
Published
February 7, 2017
Content info
62 Pages
Price
USD 6100
Sample available
NPS+ (EU5) [Parkinson's Disease]
Published by
FirstWord
Product code
488064
Published
February 1, 2017
Content info
 
Price
USD 2575
Sample available
NPS+ (US) [Parkinson's Disease]
Published by
FirstWord
Product code
488063
Published
February 1, 2017
Content info
 
Price
USD 2575
Sample available
PharmaFocus: Tauopathies - Global Market Analysis
Published by
GlobalData
Product code
479772
Published
February 1, 2017
Content info
196 Pages
Price
USD 9495
Sample available
Multiple Sclerosis Forecast in 18 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
425865
Published
January 26, 2017
Content info
98 Pages
Price
USD 6100
Sample available
Vascular Dementia Forecast in 13 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
422539
Published
January 19, 2017
Content info
50 Pages
Price
USD 6100
Sample available
Muscular Dystrophies Forecast in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
422288
Published
January 18, 2017
Content info
44 pages
Price
USD 6100
Sample available
Global Myasthenia Gravis Drugs Market 2017-2021
Published by
TechNavio (Infiniti Research Ltd.)
Product code
422872
Published
January 12, 2017
Content info
73 Pages
Price
USD 3500
Sample available
Parkinson's Disease - Heat Map and Analysis
Published by
GBI Research
Product code
440736
Published
January 9, 2017
Content info
20 Pages
Price
USD 2000
Sample available
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
410989
Published
December 30, 2016
Content info
40 Pages
Price
USD 2000
Sample available
Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
410973
Published
December 30, 2016
Content info
35 Pages
Price
USD 2000
Sample available
Multiple Sclerosis - Pipeline Review, H2 2016
Published by
Global Markets Direct
Product code
232855
Published
December 21, 2016
Content info
928 Pages
Price
USD 2500
Sample available
Neurological Disorder Drugs Market (Disorder - Epilepsy, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Cerebrovascular Disease; Drug Type) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Published by
Transparency Market Research
Product code
410942
Published
December 16, 2016
Content info
224 Pages
Price
USD 5795
Sample available
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments
Published by
GBI Research
Product code
219212
Published
December 1, 2016
Content info
133 Pages
Price
USD 4995
Sample available